Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

D Stolz, T Mkorombindo, DM Schumann, A Agusti… - The Lancet, 2022 - thelancet.com
Executive summary Despite substantial progress in reducing the global impact of many non-
communicable diseases, including heart disease and cancer, morbidity and mortality due to …

The path to healthy ageing in China: a Peking University–Lancet Commission

X Chen, J Giles, Y Yao, W Yip, Q Meng, L Berkman… - The Lancet, 2022 - thelancet.com
Executive summary Around the world, populations are ageing at a faster pace than in the
past and this demographic transition will have effects on all aspects of societies. In May …

[HTML][HTML] The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

KB Tran, JJ Lang, K Compton, R Xu, AR Acheson… - The Lancet, 2022 - thelancet.com
Background Understanding the magnitude of cancer burden attributable to potentially
modifiable risk factors is crucial for development of effective prevention and mitigation …

Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …

JM Kocarnik, K Compton, FE Dean, W Fu… - JAMA …, 2022 - jamanetwork.com
Importance The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD
2019) provided systematic estimates of incidence, morbidity, and mortality to inform local …

Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action

X Dai, E Gakidou, AD Lopez - Tobacco control, 2022 - tobaccocontrol.bmj.com
Background Despite compelling evidence on the health hazards of tobacco products
accumulated over the past 70 years, smoking remains a leading cause of death worldwide …

[HTML][HTML] Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019

HH Kyu, A Vongpradith, SB Sirota… - The Lancet infectious …, 2022 - thelancet.com
Background The global burden of lower respiratory infections (LRIs) and corresponding risk
factors in children older than 5 years and adults has not been studied as comprehensively …

Health effects associated with smoking: a Burden of Proof study

X Dai, GF Gil, MB Reitsma, NS Ahmad, JA Anderson… - Nature medicine, 2022 - nature.com
As a leading behavioral risk factor for numerous health outcomes, smoking is a major
ongoing public health challenge. Although evidence on the health effects of smoking has …

Recent updates on bioactive properties of linalool

Q An, JN Ren, X Li, G Fan, SS Qu, Y Song, Y Li… - Food & function, 2021 - pubs.rsc.org
Natural products, including essential oils and their components, have been used for their
bioactivities. Linalool (2, 6-dimethyl-2, 7-octadien-6-ol) is an aromatic monoterpene alcohol …

The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling …

S Chen, M Kuhn, K Prettner, F Yu, T Yang… - The Lancet Global …, 2023 - thelancet.com
Background Chronic obstructive pulmonary disease (COPD) is the third leading cause of
death worldwide and imposes a substantial economic burden. Gaining a thorough …

The effect of smoking on humoral response to COVID-19 vaccines: a systematic review of epidemiological studies

P Ferrara, V Gianfredi, V Tomaselli, R Polosa - Vaccines, 2022 - mdpi.com
While the role of active smoking on response to vaccines is yet to be fully understood, some
real-world studies have outlined a possible link between smoking and humoral response to …